A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy
未受抗生素干扰的肠道微生物群与CD19-CAR-T细胞癌症免疫疗法的临床疗效相关。
期刊:Nature Medicine
影响因子:58.7
doi:10.1038/s41591-023-02234-6
Christoph K Stein-Thoeringer # ,Neeraj Y Saini # ,Eli Zamir # ,Viktoria Blumenberg # ,Maria-Luisa Schubert # ,Uria Mor ,Matthias A Fante ,Sabine Schmidt ,Eiko Hayase ,Tomo Hayase ,Roman Rohrbach ,Chia-Chi Chang ,Lauren McDaniel ,Ivonne Flores ,Rogier Gaiser ,Matthias Edinger ,Daniel Wolff ,Martin Heidenreich ,Paolo Strati ,Ranjit Nair ,Dai Chihara ,Luis E Fayad ,Sairah Ahmed ,Swaminathan P Iyer ,Raphael E Steiner ,Preetesh Jain ,Loretta J Nastoupil ,Jason Westin ,Reetakshi Arora ,Michael L Wang ,Joel Turner ,Meghan Menges ,Melanie Hidalgo-Vargas ,Kayla Reid ,Peter Dreger ,Anita Schmitt ,Carsten Müller-Tidow ,Frederick L Locke ,Marco L Davila ,Richard E Champlin ,Christopher R Flowers ,Elizabeth J Shpall ,Hendrik Poeck ,Sattva S Neelapu ,Michael Schmitt ,Marion Subklewe ,Michael D Jain ,Robert R Jenq ,Eran Elinav
T细胞
细胞生物学
微生物学
肿瘤
CD19
T细胞
肿瘤免疫
免疫/内分泌